Ngl Fine Chem Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of NGL Fine Chem Ltd is ₹ 2428 as of 05 May 15:30 . The P/E Ratio of NGL Fine Chem Ltd changed from 16.7 on March 2021 to 32.6 on March 2025 . This represents a CAGR of 14.31% over 5 yearsThe P/E Ratio of Remus Pharmaceuticals Ltd changed from 49.4 on March 2024 to 45.4 on March 2025 . This represents a CAGR of -4.13% over 2 years The Market Cap of NGL Fine Chem Ltd changed from ₹ 947.42 crore on March 2021 to ₹ 688.7 crore on March 2025 . This represents a CAGR of -6.18% over 5 yearsThe Market Cap of Remus Pharmaceuticals Ltd changed from ₹ 1016 crore on March 2024 to ₹ 1319 crore on March 2025 . This represents a CAGR of 13.93% over 2 years The revenue of NGL Fine Chem Ltd for the Dec '25 is ₹ 132.12 crore as compare to the Sep '25 revenue of ₹ 122.31 crore. This represent the growth of 8.02% The revenue of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of NGL Fine Chem Ltd for the Dec '25 is ₹ 26.93 crore as compare to the Sep '25 ebitda of ₹ 19.21 crore. This represent the growth of 40.19% The ebitda of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of NGL Fine Chem Ltd changed from ₹ 9.22 crore to ₹ 15.69 crore over 7 quarters. This represents a CAGR of 35.50% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of NGL Fine Chem Ltd changed from 1.95 % on March 2021 to 5.97 % on March 2025 . This represents a CAGR of 25.08% over 5 yearsThe Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 years .

About NGL Fine Chem Ltd

NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra.
The Company became a Public Limited Company.
The Company has got its registered office and factory at New Bombay.
It was promoted by Mr. A.G.Lawande, Mr.R. J. Nachane joined Mr.A.G.Lawande for actively participating in the Management of the Company in 1989.
The Company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

FAQs for the comparison of NGL Fine Chem Ltd and Remus Pharmaceuticals Ltd

Which company has a larger market capitalization, NGL Fine Chem Ltd or Remus Pharmaceuticals Ltd?

Market cap of NGL Fine Chem Ltd is 1,389 Cr while Market cap of Remus Pharmaceuticals Ltd is 844 Cr

What are the key factors driving the stock performance of NGL Fine Chem Ltd and Remus Pharmaceuticals Ltd?

The stock performance of NGL Fine Chem Ltd and Remus Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for NGL Fine Chem Ltd and Remus Pharmaceuticals Ltd?

As of May 5, 2026, the NGL Fine Chem Ltd stock price is INR ₹2248.75. On the other hand, Remus Pharmaceuticals Ltd stock price is INR ₹716.8.

How do dividend payouts of NGL Fine Chem Ltd and Remus Pharmaceuticals Ltd compare?

To compare the dividend payouts of NGL Fine Chem Ltd and Remus Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.